Dr. John F. Centonze, MD

Dr. Centonze practices at Rochester General Hospital in Rochester, New York, part of Rochester Regional Health.

Dr. Centonze's NPI, 1073535480, was assigned on July 24, 2006. Dr. Centonze graduated from Jacobs School of Medicine and Biomedical Sciences in 1987. Dr. Centonze holds New York license 203166.

Dr. Centonze's primary practice is Rochester General Hospital, at 1425 Portland Avenue, Rochester, NY 14621 in Monroe County. The practice phone is (585) 922-4000.

Dr. Centonze's primary practice is Rochester General Hospital in Rochester, New York, part of Rochester Regional Health. Dr. Centonze is also affiliated with Clifton Springs Hospital and Clinic. The medical group on file is Rochester General Hospital. Dmand AI also links Dr. Centonze to 2 more hospitals, 3 group practices and clinics, 2 medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Centonze practices, 8 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Centonze's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Centonze is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Centonze's licenses on file in 2 states: New York and Georgia.

Dmand AI lists acute sinusitis, chronic nasal allergies, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment, larynx and vocal cord disease and swimmer's ear among the conditions Dr. Centonze treats.

CMS data shows 1,213 Medicare services from Dr. Centonze across 4 procedure codes in 2024, for 110 Medicare patients. Medicare paid $14,428 for them. Every service was in an office.

CMS counts 110 Medicare patients who saw Dr. Centonze in 2024. The largest group is 65 to 74, with 45 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 35% are also on Medicaid. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Centonze's median patient age at 60, with 56% women.

In 2024, Dr. Centonze wrote 567 Medicare Part D claims for 198 patients. 91% of them were for generic drugs. CMS names the drug for 453 of them, across 11 drugs with 11 or more claims each, at $62,154 in total drug cost. In 2023, CMS named 787 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Centonze for performance year 2024, reported through an alternative payment model (APM). Dr. Centonze accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 162 general payments to Dr. Centonze from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 69% of the total. Aerin Medical Inc. paid the most, $1,658.

Dmand AI lists 1 award for Dr. Centonze.

Dr. Centonze graduated from Jacobs School of Medicine and Biomedical Sciences in 1987. Dr. Centonze is a member of NHS.

Dr. Centonze is in network with 10 carriers, including Aetna, MVP Health Care and Highmark. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.